---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-020241"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2023-06-06T23:59:59+00:00"
generated_at: "2026-06-14T06:29:22.046276+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics effects 1-for-30 reverse stock split effective June 5, 2023

## Summary
- 1-for-30 reverse split of common stock and warrants effective June 5, 2023; par value unchanged.
- Stockholder approval via written consent on May 1, 2023; no fractional shares, rounding up.
- Trading on Nasdaq on split-adjusted basis from June 7, 2023; new CUSIP 098070402 (common) and 098070154 (warrants).
- Proportionate adjustments to exercise prices and shares reserved under equity plans and outstanding options/warrants.

## SEC filing metadata
- accession: 0001493152-23-020241
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2023-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315223020241/0001493152-23-020241-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315223020241/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-020241
- JSON: https://secwatch.observer/filing/0001493152-23-020241.json
- Plain text: https://secwatch.observer/filing/0001493152-23-020241.txt

## Key facts
- Governance Changes
  Bone Biologics Corp: Amendment to Certificate of Incorporation to effect a 1-for-30 reverse stock split (effective 2023-06-05).
  - Change: charter amendment
  - Effective: 2023-06-05
  source text: On June 5, 2023, Bone Biologics Corporation (the “Company”) filed an amendment to its Certificate of Incorporation, as amended, (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-30 reverse stock split of its outstanding common stock and warrants.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315223020241/0001493152-23-020241-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.